Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glucocorticosteroids for viral hepatitis C.

J Brok1, M T Mellerup, K Krogsgaard

  • 1Centre for Clinical Intervention Research, Copenhagen University Hospital, Department 7102, H:S Rigshospitalet, Copenhagen Ø, Denmark, DK 2100.

The Cochrane Database of Systematic Reviews
|April 24, 2004
PubMed
Summary

Glucocorticosteroids show no significant benefit or harm for chronic hepatitis C patients. More research is needed to confirm effects and rule out serious adverse events in hepatitis C virus patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adherence to Protocol Recommendations for Children With Wilms Tumour in Two Consecutive Studies in the United Kingdom and Ireland-Does Variation Matter?

Pediatric blood & cancer·2026
Same author

The risks of adverse events with venlafaxine for adults with major depressive disorder: a systematic review of randomised clinical trials with meta-analysis and Trial Sequential Analysis.

Epidemiology and psychiatric sciences·2024
Same author

Tramadol for chronic pain in adults: protocol for a systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.

Systematic reviews·2023
Same author

Risk factors associated with nausea and vomiting in children with cancer receiving chemotherapy.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2022
Same author

Fifty years of clinical and research studies for childhood renal tumors within the International Society of Pediatric Oncology (SIOP).

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Effect of metformin and insulin vs. placebo and insulin on whole body composition in overweight patients with type 2 diabetes: a randomized placebo-controlled trial.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2021

Area of Science:

  • Hepatology
  • Clinical Pharmacology

Background:

  • Hepatitis C virus (HCV) infection can lead to liver inflammation and fibrosis.
  • The role of glucocorticosteroids in managing HCV infection remains unclear.

Purpose of the Study:

  • To assess the efficacy and safety of glucocorticosteroids in patients with acute or chronic hepatitis C.
  • To evaluate outcomes in patients with or without HCV-related autoimmune disorders.

Main Methods:

  • Systematic review of randomized clinical trials.
  • Searches conducted across multiple databases (Cochrane Hepato-Biliary, CENTRAL, MEDLINE, EMBASE) up to July 2003.
  • Data extraction and validation by two independent reviewers.

Main Results:

  • Eight trials involving 384 patients with chronic hepatitis C were analyzed.

Related Experiment Videos

  • Glucocorticosteroids combined with interferon showed no significant impact on mortality, virological, or biochemical response compared to interferon monotherapy.
  • No trials investigated glucocorticosteroids for acute hepatitis C.

    • Conclusions:

    • Insufficient evidence exists to confirm or refute the benefits or harms of glucocorticosteroids in chronic hepatitis C.
    • Potential serious adverse effects of glucocorticosteroids cannot be excluded.
    • The safety of glucocorticosteroids in patients with underlying HCV infection requires further investigation.